The Medicines Company
CompanyUnited States
The Medicines Company develops one asset, in phase 3 (inclisiran in acute coronary syndrome). Mostly oligonucleotide acting on lipid and ceramide metabolism and PCSK9; based in the United States.
- Assets
- 1
- Furthest
- Phase 3
- Trials
- 6
- Signals
- 0
Pipeline
1siRNA that targets PCSK9 mRNA to lower LDL cholesterol.
Phase 3OligonucleotideLipid and ceramide metabolismPCSK9acute coronary syndromeascvd
Full company profiles: pipeline, trials, funding and people.
See Pro- Evidence behind the mechanisms3
- Trials7
- Signals2
- Similar companies6
Updated 7 Oct 2026 · 32 sources